About Genalyte
Genalyte, Inc. is a life sciences company developing and commercializing innovative next-generation multiplexing technology. Genalyte has developed a new approach to immunodetection using silicon chip manufacturing methods. Its Maverick platform uses a technology called silicon photonics to directly measure protein binding between antibodies and antigens or hybridization of nucleic acids.
Open positions (1)
Company details
Funding
Total raised
$142M
Last stage
Series C
Investors
Founders
Cary Gunn
Founder of Genalyte and co-founder/CTO of Luxtera. PhD in Electrical Engineering from Caltech. Nearly 10 years in the US Air Force. Holds 81+ US patents. Named MIT Technology Review Top Young Innovator in 2003.
LinkedInAshraf Hanna
Joined Genalyte as CEO from Verily (Google Life Sciences) where he was COO. Previously VP at Genentech and McKinsey. PhD in Physics from Harvard, MD from University of Massachusetts.
What happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.